E!10397 DEVELOPING AN INNOVATIVE OXGEN-BASED TECHNOLOGY FOR WOUND HEALING: MORE EFFICIENT AND LESS COSTLY

Wound care accounts for 4% of total healthcare costs and is expected to grow significantly with the ageing population. Current treatments are not satisfactory, requiring multiple products and being labor-intensive. Oxygen plays an important role, increasing wound healing rate. Through this project an innovative technology for treatment of chronic wounds has been developed. Insufficient oxygenation of wounds, due to poor blood circulation impairs proper wound healing. A prefabricated oxygenated dressing is developed and has been tested for wound healing efficacy bot in vitro and in vivo. Furthermore, a medium-scale production, evaluation and testing of packaging and a shelf life corresponding to 2 years have been performer. A prerequisite for development and evaluation of the product is an improved analytical technique. Therefore, the project has developed and delivered a technology for accurate oxygen measurements. One scientific article has been published and one patent has been applied for. A WOUND CARE PRODUCT WITH HIGH, STABLE, AND CONTROLLED OXYGEN LEVELS, HAS BEEN DELIVERED IN THIS PROJECT.

1) Utvidet forståelse av de basale mekanismene av oksygen i prosessen for sårtilheling - bidrar til å øke kunnskapen innenfor fagfeltet 2) Basert på teknologien som er utviklet på monitorering av oksygen er det startet opp et nytt selskap i Sverige. Dette vil på sikt bidra til økte arbeidsplasser. 3) Prosjektet har bidratt til utvikling av et nytt sårhelingsprodukt som vil kunne bidra til å få sår til å gro raskere. Dette vil igjen kunne føre til reduserte sykehusdøgn på denne type pasienter og dermed reduserte helsekostnader. Samt vil produtet gjøre at pasientene blir mer mobile da produktet kan brukes også hjemmenfra. 4) Selskapet har raskere og mer effektivt kunne forske fram og utvikle et høy oksygenert sårhelingsprodukt. Uten støtte ville progressen vært mye langsommere. 5) Finansieringen gjør det også enklere for selskapet å inhente ny kapital 6) Økt tverrfaglig samarbeide både internasjonalt og nasjonalt

Wound care accounts for 4% of total healthcare costs and is expected to grow significantly with the ageing population. Current treatments are not satisfactory, requiring multiple products and being labor-intensive. Oxygen plays an important role, increasing wound healing rate. Taking advantage of our established technology of producing highly oxygenated liquid, a dressing will be developed. The unique product will take shares from the medical device market and increase revenue to the consortium. Through this project an innovative technology for treatment of chronic wounds will be developed. Insufficient oxygenation of wounds, due to poor blood circulation impairs proper wound healing. A prefabricated oxygenated dressing with significant wound healing efficacy and low cost will be delivered. A prerequisite for development and evaluation of the product is an improved analytical technique. Therefore, the project will also include refinement of a technology for accurate oxygen measurements. A WOUND CARE PRODUCT WITH HIGH, STABLE (up to 7 hours), AND CONTROLLED OXYGEN LEVELS, WITH PROVEN CLINICAL EFFICACY, AND PRODUCT STABILITY BOTH WHEN APPLIED AND ON THE SHELF WILL BE DELIVERED TROUGH THIS PROJECT.